Jurabek Laboratories, where Uzbekistan plans to produce the Russian Sputnik V vaccine, has passed quality control in the Russian Federation and will begin mass production of the jab next week, said the company CEO Farrukh Lutfullaev.
He added that the Gamaleya National Research Center for Epidemiology and Microbiology received positive results on the quality of the first validation batch of Sputnik V, which was received in July.
“We received a positive response from Russia in terms of quality. Now we are waiting for raw materials from Russia, next week we will start bottling,” Lutfullaev said.
Earlier, Jurabek Laboratories said that at the initial stage, the company plans to produce up to two million doses of Sputnik V per month.
